Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplantation for Marginal Zone Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 3027.

https://doi.org/10.1182/blood-2024-194632

Published: 2024

Journal Articles

Outcome of Hematopoietic Stem Cell Transplantation for Follicular Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 749.

https://doi.org/10.1182/blood-2024-194657

Published: 2024

Journal Articles

Post-Transplant MRD Status and T Cell Chimerism Predict Outcomes in Patients Allografted for AML/MDS-a Prospective Analysis from the UK NCRI Figaro Trial

Blood (2021) 138 (Supplement 1): 415.

https://doi.org/10.1182/blood-2021-149269

Published: 2021

Journal Articles

The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial

Blood (2019) 134 (Supplement_1): 2031.

https://doi.org/10.1182/blood-2019-125646

Published: 2019

Journal Articles

Combining Clinical Features with Genetic Factors Improves Survival Prediction for Adults with Acute Myeloid Leukemia: Validation of a New Score System in 3 Cohorts

Douglas R. A. Silveira, Lynn Quek, MD PhD, Anna Corby, B.Sc., Juan L Coelho-Silva, BSc, MSc, Diego A Pereira-Martins, MSc, Grant Vallance, B.Sc., PhD, Benjamin Brown, B.Sc., PhD, Luciana Nardinelli, M.Sc, Wellington F Silva, MD, Elvira DRP Velloso, MD PhD, Fabiola Traina, MD PhD, Andy Peniket, MD, Paresh Vyas, MD PhD, Eduardo M Rego, MD PhD, Israel Bendit, MD PhD, Vanderson Rocha, MD PhD

Blood (2019) 134 (Supplement_1): 2602.

https://doi.org/10.1182/blood-2019-130726

Published: 2019

Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD

Blood (2019) 134 (Supplement_1): 4768.

https://doi.org/10.1182/blood-2019-128139

Published: 2019

Journal Articles

Age (≤75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset

Faouzi Djebbari, MSc, Faye A Sharpley, Connor Sweeney, Grant Vallance, Andy Peniket, Lisa Ferguson, Susan McLain-Smith, Jaimal Kothari, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 2154.

https://doi.org/10.1182/blood.V130.Suppl_1.2154.2154

Published: 2017

Journal Articles

Female Gonadal Function Following Reduced Intensity Conditioning (RIC) Allogeneic Bone Marrow Transplantation for Haematological Malignancies.

Chara Kyriakou, MD, Melanie Davies, MD, Ratna Chatterjee, MD, PhD, Anna Castleton, MD, Kim Roberts, Andy Peniket, MD,PhD, Stephen Mackinnon, MD, Panagiotis D. Kottaridis, MD,PhD

Blood (2006) 108 (11): 3372.

https://doi.org/10.1182/blood.V108.11.3372.3372

Published: 2006

Journal Articles

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome

Alexander Sternberg, Sally Killick, Tim Littlewood, Chris Hatton, Andy Peniket, Thomas Seidl, Shamit Soneji, Joanne Leach, David Bowen, Claire Chapman, Graham Standen, Edwin Massey, Lisa Robinson, Bipin Vadher, Richard Kaczmarski, Riaz Janmohammed, Kim Clipsham, Andrew Carr, Paresh Vyas

Blood (2005) 106 (9): 2982–2991.

https://doi.org/10.1182/blood-2005-04-1543

Published: 2005

Includes: Supplemental data

Journal Articles

hTERT , the Catalytic Component of Telomerase, Is Down-Regulated in the Hematopoietic Stem Cells of Patients with Chronic Myeloid Leukemia.

Lisa J. Campbell, Helen Eagleton, Tim J. Littlewood, Andy Peniket, Rajko Kusec, Shira Gal, Carrie Fidler, James S. Wainscoat, Jacqueline Boutlwood

Blood (2004) 104 (11): 2966.

https://doi.org/10.1182/blood.V104.11.2966.2966

Published: 2004

NARROW

Hematopoietic Stem Cell Transplantation for Marginal Zone Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Outcome of Hematopoietic Stem Cell Transplantation for Follicular Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Post-Transplant MRD Status and T Cell Chimerism Predict Outcomes in Patients Allografted for AML/MDS-a Prospective Analysis from the UK NCRI Figaro Trial

The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial

Combining Clinical Features with Genetic Factors Improves Survival Prediction for Adults with Acute Myeloid Leukemia: Validation of a New Score System in 3 Cohorts

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Age (≤75 years) and Not Choice of First-Line Therapy Improves Overall Survival in Transplant Ineligible NDMM Patients: Results from a Large UK Real-World Dataset

Female Gonadal Function Following Reduced Intensity Conditioning (RIC) Allogeneic Bone Marrow Transplantation for Haematological Malignancies.

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome

hTERT , the Catalytic Component of Telomerase, Is Down-Regulated in the Hematopoietic Stem Cells of Patients with Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only